Each week we highlight five things affecting the life sciences industry. Here's the latest. FDA releases final rule on laboratory developed tests On April 29, the U.S. Food and Drug Administration issued a final rule regarding regulation of laboratory developed tests, following a proposed rule in ... READ MORE >
life sciences
Key takeaways for life sciences on laboratory developed tests final rule
The U.S. Food and Drug Administration released a final rule yesterday regarding the regulation of laboratory developed tests, also known as LDTs. This final rule follows a proposed rule that was released last fall. While the final rule closely follows the proposed rule released late last year, there are ... READ MORE >
5 things to know in life sciences: Week of April 22, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Orphan drug market to reach $270 billion by 2028 despite decreasing growth rates According to data from Evaluate, the orphan drug market is projected to expand to $270 billion by 2028. This sector, while ... READ MORE >
5 things to know in life sciences: Week of April 15, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. EU launches probe into China's medical device market practices According to Reuters, the European Union is set to begin an investigation into China's medical device procurement practices, concerned that ... READ MORE >
5 things to know in life sciences: Week of April 8, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Women-led health tech ventures in Africa experience 2,000% funding growth Funding for women-led health tech ventures in Africa increased from 1% of total funding in 2022 to 31% in 2023, with the amount rising ... READ MORE >
5 things to know in life sciences: Week of April 1, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Navigating the future of biopharma collaborations amid U.S.-China tensions Per BioSpace, political and legislative changes are creating uncertainty for Chinese and U.S. biopharma collaborations, particularly ... READ MORE >
5 things to know in life sciences: Week of March 25, 2024
Each week we highlight five things affecting the life sciences industry. Here’s the latest. FDA issues warnings on plastic syringes from China According to MedTech Dive, the U.S. Food and Drug Administration has issued three warning letters as part of its investigation into plastic syringes made in ... READ MORE >
5 things to know in life sciences: Week of March 18, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Revolutionizing surgery: Nvidia and Johnson & Johnson's AI collaboration Per CNBC, Nvidia and Johnson & Johnson are collaborating to develop new artificial intelligence applications for surgery, ... READ MORE >
5 things to know in life sciences: Week of March 11, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Public biotech financings on pace for best quarter since 2021 According to Biopharma Dive, publicly traded biotech companies have raised nearly $10 billion in follow-on stock offerings during the first ... READ MORE >
5 things to know in life sciences: Week of March 4, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Biden administration receives counteroffers from drug companies The Biden administration has received counteroffers from drug manufacturers in Medicare price negotiations under the Inflation Reduction Act, ... READ MORE >